Page last updated: 2024-09-04

ezetimibe and dalcetrapib

ezetimibe has been researched along with dalcetrapib in 4 studies

Compound Research Comparison

Studies (ezetimibe)	Trials (ezetimibe)	Recent Studies (post-2010) (ezetimibe)	Studies (dalcetrapib)	Trials (dalcetrapib)	Recent Studies (post-2010) (dalcetrapib)
2,484	563	1,465	166	38	103

Protein Interaction Comparison

Protein	Taxonomy	ezetimibe (IC50)	dalcetrapib (IC50)
Cholesteryl ester transfer protein	Homo sapiens (human)		4.1

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	4 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Rosenson, RS	1
Abt, M; Derks, M; Phelan, M	1
Blum, D; Chaput, E; Derks, M; Kallend, D; Niesor, EJ; Staempfli, A	1
Akinsanya, KO; Castro-Perez, J; Chen, Y; Daniels, E; Johns, DG; Previs, SF; Roddy, TP; Wang, SP; Zhou, H	1

Trials

2 trial(s) available for ezetimibe and dalcetrapib

Article	Year
Lack of clinically relevant drug-drug interactions when dalcetrapib is co-administered with ezetimibe. British journal of clinical pharmacology, 2010, Volume: 70, Issue:6 Topics: Adolescent; Adult; Aged; Amides; Anticholesteremic Agents; Azetidines; Cross-Over Studies; Drug Administration Schedule; Drug Interactions; Esters; Ezetimibe; Humans; Hypertension; Lipids; Male; Middle Aged; Sulfhydryl Compounds; Young Adult	2010
Effect of dalcetrapib, a CETP modulator, on non-cholesterol sterol markers of cholesterol homeostasis in healthy subjects. Atherosclerosis, 2011, Volume: 219, Issue:2 Topics: Amides; Animals; Anticholesteremic Agents; Azetidines; Biomarkers; Cholestanol; Cholesterol; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Cricetinae; Cross-Over Studies; Desmosterol; Esters; Ezetimibe; Homeostasis; Humans; Intestinal Absorption; Lipid Metabolism; Male; Mesocricetus; Models, Animal; Phytosterols; Quinolines; Sitosterols; Sulfhydryl Compounds; Switzerland	2011

Article

Year

Lack of clinically relevant drug-drug interactions when dalcetrapib is co-administered with ezetimibe.

British journal of clinical pharmacology, 2010, Volume: 70, Issue:6

Topics: Adolescent; Adult; Aged; Amides; Anticholesteremic Agents; Azetidines; Cross-Over Studies; Drug Administration Schedule; Drug Interactions; Esters; Ezetimibe; Humans; Hypertension; Lipids; Male; Middle Aged; Sulfhydryl Compounds; Young Adult

2010

Effect of dalcetrapib, a CETP modulator, on non-cholesterol sterol markers of cholesterol homeostasis in healthy subjects.

Atherosclerosis, 2011, Volume: 219, Issue:2

Topics: Amides; Animals; Anticholesteremic Agents; Azetidines; Biomarkers; Cholestanol; Cholesterol; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Cricetinae; Cross-Over Studies; Desmosterol; Esters; Ezetimibe; Homeostasis; Humans; Intestinal Absorption; Lipid Metabolism; Male; Mesocricetus; Models, Animal; Phytosterols; Quinolines; Sitosterols; Sulfhydryl Compounds; Switzerland

2011

Other Studies

2 other study(ies) available for ezetimibe and dalcetrapib

Article	Year
Functional assessment of HDL: Moving beyond static measures for risk assessment. Cardiovascular drugs and therapy, 2010, Volume: 24, Issue:1 Topics: Amides; Animals; Anticholesteremic Agents; Azetidines; Cardiovascular Diseases; Cholesterol; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Esters; Ezetimibe; Glucose; Humans; Insulin; Lipase; Lipoproteins, HDL; Niacin; Quinolines; Risk Assessment; Risk Factors; Sulfhydryl Compounds	2010
In vivo effects of anacetrapib on preβ HDL: improvement in HDL remodeling without effects on cholesterol absorption. Journal of lipid research, 2013, Volume: 54, Issue:10 Topics: Amides; Animals; Anticholesteremic Agents; Area Under Curve; Azetidines; Cholesterol; Cholesterol Ester Transfer Proteins; Cricetinae; Diet, High-Fat; Drug Evaluation, Preclinical; Dyslipidemias; Esters; Ezetimibe; High-Density Lipoproteins, Pre-beta; Humans; Intestinal Absorption; Male; Mesocricetus; Oxazolidinones; Sulfhydryl Compounds	2013

Article

Year

Functional assessment of HDL: Moving beyond static measures for risk assessment.

Cardiovascular drugs and therapy, 2010, Volume: 24, Issue:1

Topics: Amides; Animals; Anticholesteremic Agents; Azetidines; Cardiovascular Diseases; Cholesterol; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Esters; Ezetimibe; Glucose; Humans; Insulin; Lipase; Lipoproteins, HDL; Niacin; Quinolines; Risk Assessment; Risk Factors; Sulfhydryl Compounds

2010

In vivo effects of anacetrapib on preβ HDL: improvement in HDL remodeling without effects on cholesterol absorption.

Journal of lipid research, 2013, Volume: 54, Issue:10

Topics: Amides; Animals; Anticholesteremic Agents; Area Under Curve; Azetidines; Cholesterol; Cholesterol Ester Transfer Proteins; Cricetinae; Diet, High-Fat; Drug Evaluation, Preclinical; Dyslipidemias; Esters; Ezetimibe; High-Density Lipoproteins, Pre-beta; Humans; Intestinal Absorption; Male; Mesocricetus; Oxazolidinones; Sulfhydryl Compounds

2013